Overview

Cardiac Monitoring and Cardiac Rhythm Management Devices Market is estimated to value over USD 32 billion by 2027 end and register a CAGR of over 4.8% during the forecast period 2020 to 2027.

The surge of patients suffering from ailments such as heart failure and recurrent arrhythmias has contributed significantly to the cardiac rhythm management (CRM) devices market. This market has seen exponential growth due to technological progress, cardiac disorders, a greater awareness among patients and a rise in the untreated medical conditions in developing nations. But despite all the advancements, the market still encounters some hindrances such as the exorbitant costs, lack of insurance coverage alternatives and an inclination to choose drugs over treatment devices. All these factors are especially prevalent in developing nations. Having said that, the developments in the latest MRI-labeled devices, along with the growth in the economies of LAMEA and Asia-Pacific regions have been predicted to augment the growth of the industries involved in the manufacture of cardiac rhythm management and cardiac monitoring.

Segmentation-wise, the market has been bifurcated into cardiac rhythm management and cardiac monitoring. These two segments have been divided into cardiac rhythm management devices and conventional monitoring devices. Here, the monitoring device has been categorised into event monitors, cardiac monitors, ECG, Holter monitors and ILR (implantable loop recorder). Cardiac rhythm management (CRM) has been classified into sub-segments which includes defibrillators, pacemakers and cardiac resynchronization devices.

Electrocardiography (ECG) market has been anticipated to account for the largest segment in the forecast time frame, while ILR is predicted to be the fastest growing segment and pacemakers and defibrillators are widely used in the area of diagnostics. These are likely to exhibit robust growth in the next six years because they are, in fact, the most mature market. Cardiac telemetry and ECG data management are two such systems that are highly up to date and will demonstrate positive changes in the ambulatory and home health care services.

The segmentation of the end users are home health care facilities, hospitals and ambulatory services. The ease of treatment and the affordability of the ambulatory and home health care facilities rank as some of the main factors in the substantial market growth.

Key players in this market includes
Abbott Laboratories, Medtronic, PLC, Boston Scientific Corporation, GE Healthcare, Koninklijke Philips N.V., Biotronik, Asahi Kasei Corporation, Microport Scientific Corporation, Hill-Rom Holdings, Nihon Kohden Corporation, Schiller, ACS Diagnostics, BPL Medical Technologies, Osypka AG, Alivecor, Inc.

Cardiac Monitoring and Cardiac Rhythm Management Devices Market

Cardiac Monitoring and & Cardiac Rhythm Management Devices Market Segmentation:

By Type

Ecg Devices
Resting Ecg Devices
Stress Ecg Devices
Holter Monitors
Implantable Loop Recorders
Mobile Cardiac Telemetry Devices
Cardiac Output Monitoring Devices
Event Monitors
By Type
By Technology
Smart Ecg Monitors
Defibrillators
Implantable Cardioverter Defibrillators
External Defibrillators
Pacemakers
By Implantability
By Type

By End User

Hospitals, Clinics, & Cardiac Centers
Ambulatory Surgery Centers
Other

By Region

North America
Europe
Asia Pacific
Rest of the World

FutureWise Key Takeaways:

Growth prospects
SWOT analysis
Key trends
Key data-points affecting market growth

Objectives of the Study:

To provide with an exhaustive analysis on the Cardiac Monitoring and & Cardiac Rhythm Management Devices Market market by type, by end user and by region
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East & Africa
To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
Profiling of companies to evaluate their market

Flexible Delivery Model:

•   We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•   The customization Mobility Care offered are free of charge with purchase of any license of the report
•   You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com